Idis Clinical Trial Procurement Strategies
Partnering with Idis to develop an Idis Clinical Trial Procurement Strategy will:
- Allow you to confidentially access drugs from anywhere in the world
- Guarantee regulatory compliance and secure the necessary product documentation
- Guarantee genuine products and full batch traceability
- Guarantee long-term, flexible comparator supply
- Enable you to plan proactively for significant, sustainable savings
- Reduce your exposure to regulatory, operational and financial risks
Today's challenge
As trials become more complex, the risks associated with comparator procurement increase. Not gaining reliable access to comparators can delay your trial or even lead to its early termination, making it critical that you secure comparators using a proven strategy.
Idis Clinical Trial Procurement Strategies can help you do just that. We help protect your investment in clinical trials through the development of reliable, cost-effective comparator solutions that leverage our unrivalled network to access drugs from anywhere in the world.
Risk mitigation
We'll help you mitigate the regulatory, operational and financial risks associated with comparator procurement, including counterfeit dangers, over/under ordering, formulation changes, confidentiality and product recalls to name a few. In addition, we can also conduct market assessments to identify barriers and opportunities that may influence your choice of comparator, for example predicted discontinuation, reducing the risk of delays to your programme.
Therapeutic experience
As market leaders in our field we’re highly experienced in gaining robust and secure access to a wide range of comparators across a diverse range of therapeutic areas. In particular, we have extensive knowledge in oncology.
By consulting with Idis, you can rest assured that whatever your comparator needs and whatever your therapeutic area, we will have a solution to suit you.
Regulatory experience
Our consultants are in regular communication with key regulatory authorities and understand global regulatory requirements that govern comparator sourcing and use. We also have extensive relationships with drug manufacturers that allow us to secure the necessary documentation for your comparator.
To consult with Idis about procurement strategies, please contact
Simon Estcourt
